BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 34147651)

  • 1. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hosts.
    Magateshvaren Saras MA; Patro LPP; Uttamrao PP; Rathinavelan T
    Zoonoses Public Health; 2022 Nov; 69(7):816-825. PubMed ID: 35614572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    Wu S; Tian C; Liu P; Guo D; Zheng W; Huang X; Zhang Y; Liu L
    J Med Virol; 2021 Apr; 93(4):2132-2140. PubMed ID: 33090512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021.
    J Al-Awaida W; Jawabrah Al Hourani B; Swedan S; Nimer R; Alzoughool F; J Al-Ameer H; E Al Tamam S; Alashqar R; Al Bawareed O; Gushchina Y; Samy Abousenna M; Ayyash AM; Sharab A; M Alnaimat S; Imraish A; W Akash M; R Hadi N
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.
    Saha I; Ghosh N; Pradhan A; Sharma N; Maity D; Mitra K
    Brief Bioinform; 2021 Mar; 22(2):1106-1121. PubMed ID: 33725111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins.
    Sia BZ; Boon WX; Yap YY; Kumar S; Ng CH
    F1000Res; 2022; 11():9. PubMed ID: 35707000
    [No Abstract]   [Full Text] [Related]  

  • 10. Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?
    Menasria T; Aguilera M
    Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations.
    Periwal N; Rathod SB; Sarma S; Johar GS; Jain A; Barnwal RP; Srivastava KR; Kaur B; Arora P; Sood V
    Microbiol Spectr; 2022 Oct; 10(5):e0121922. PubMed ID: 36069583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.
    Sahin E; Bozdayi G; Yigit S; Muftah H; Dizbay M; Tunccan OG; Fidan I; Caglar K
    J Med Virol; 2021 Oct; 93(10):6016-6026. PubMed ID: 34241906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.
    Ghosh N; Saha I; Nandi S; Sharma N
    Methods; 2022 Jul; 203():282-296. PubMed ID: 34547443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
    Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
    Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan.
    Ghanchi NK; Nasir A; Masood KI; Abidi SH; Mahmood SF; Kanji A; Razzak S; Khan W; Shahid S; Yameen M; Raza A; Ashraf J; Ansar Z; Dharejo MB; Islam N; Hasan Z; Hasan R
    PLoS One; 2021; 16(8):e0256451. PubMed ID: 34464419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.
    Alosaimi B; Naeem A; Alghoribi MF; Okdah L; Hamed ME; AlYami AS; Alotaibi A; Enani M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.
    Martin R; Li J; Parvangada A; Perry J; Cihlar T; Mo H; Porter D; Svarovskaia E
    Antiviral Res; 2021 Apr; 188():105033. PubMed ID: 33549572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.